EUVIMEDEUVIMED entdecken
Open Access

Association of Type 2 Diabetes Subgroups With Incident Peripheral Neuropathy

Kahlia S Simpkins, Ashok Balasubramanyam iD, Scott J Pilla iD, Alain G Bertoni, Haiying Chen iD, Michelle M Mielke iD, Chinenye O Usoh iD, Lynne Wagenknecht, Mark A Espeland, Michael P Bancks iD

Diabetes Obesity and Cardiometabolic CARE · 2026

DOI: 10.2337/doc25-0051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Obesity and Cardiometabolic CARE, 2026. Verfasst von Kahlia S Simpkins und 9 weiteren Autor:innen. Beteiligte Einrichtung: Winston-Salem State University, Winston-Salem, NC. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCRR NIH HHS, NIA NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Peripheral neuropathy (PN) is a complication of type 2 diabetes (T2D). Whether T2D subgroups differ in PN risk and modify the effect of intensive lifestyle intervention (ILI) on PN prevention remains unknown. We assessed 1) whether T2D subgroups were associated with the incidence of PN and 2) whether the impact of ILI compared with control on risk for PN differed by T2D subgroups. RESEARCH DESIGN AND METHODS We included 2,891 Look AHEAD (Action for Health in Diabetes) participants with T2D and overweight or obesity randomly assigned to ILI or diabetes support and education (DSE). We used k-means clustering techniques with data on BMI, waist circumference, age of diabetes diagnosis, and glycated hemoglobin (HbA1c) to characterize T2D subgroups at randomization. PN was ascertained using the Michigan Neuropathy Screening Instrument questionnaire and physical examination. We estimated marginal probabilities for PN according to T2D subgroup with adjustment for potential confounders and attrition and examined whether ILI modified any associations. RESULTS Four distinct T2D subgroups were identified and characterized by high HbA1c, obesity, older onset, and younger onset. Incidence of PN differed by T2D subgroup (P = 0.001), and individuals in the younger onset T2D subgroup had the lowest risk for PN. The association of ILI with PN risk was null and did not differ by T2D subgroups (interaction P = 0.20). CONCLUSIONS Among individuals with T2D and overweight or obesity, the probability of developing PN differs by disease subgroups, and subgroup-specific risk does not appear to be ameliorated by lifestyle intervention.

Autor:innen und Institutionen

  • Winston-Salem State University, Winston-Salem, NC.
  • Baylor College of Medicine, Houston, TX.
  • Johns Hopkins University School of Medicine, Baltimore, MD.
  • Wake Forest University School of Medicine, Winston-Salem, NC.

ORCID-Profile: Ashok Balasubramanyam, Scott J Pilla, Haiying Chen, Michelle M Mielke, Chinenye O Usoh, Michael P Bancks

Förderung

  • NIDDK NIH HHS
  • NCRR NIH HHS
  • NIA NIH HHS
  • NIDDK
  • Centers for Disease Control and Prevention
  • NIH Office of Research on Women's Health
  • University of Colorado Health Sciences Center General Clinical Research Center
  • Harvard Clinical and Translational Science Center

Zitieren

APA

Simpkins, K. S., Balasubramanyam, A., Pilla, S. J., Bertoni, A. G., Chen, H., Mielke, M. M., Usoh, C. O., Wagenknecht, L., Espeland, M. A., & Bancks, M. P. (2026). Association of Type 2 Diabetes Subgroups With Incident Peripheral Neuropathy. Diabetes Obesity and Cardiometabolic CARE. https://doi.org/10.2337/doc25-0051

Vancouver

Simpkins KS, Balasubramanyam A, Pilla SJ, Bertoni AG, Chen H, Mielke MM, et al. Association of Type 2 Diabetes Subgroups With Incident Peripheral Neuropathy. Diabetes Obesity and Cardiometabolic CARE. 2026. doi:10.2337/doc25-0051

BibTeX
@article{Simpkins2026,
  author = {Simpkins, Kahlia S and Balasubramanyam, Ashok and Pilla, Scott J and Bertoni, Alain G and Chen, Haiying and Mielke, Michelle M and Usoh, Chinenye O and Wagenknecht, Lynne and Espeland, Mark A and Bancks, Michael P},
  title = {Association of Type 2 Diabetes Subgroups With Incident Peripheral Neuropathy},
  journal = {Diabetes Obesity and Cardiometabolic CARE},
  year = {2026},
  doi = {10.2337/doc25-0051}
}
Kostenlos starten →